Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Atara Biotherapeutics, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 17.94||$ 65.5599|
|Low||$ 16.77||$ 13.31|
The current last sale of $17.46 is 31.18% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a clinical-stage biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that have been underserved by scientific innovation. We have two groups of product candidates: (a) allogeneic or third-party derived antigen-specific T-cells, and (b) molecularly targeted biologics. T-cells are a type of white blood cell. Cytotoxic T-cells, otherwise known as cytotoxic T lymphocytes, or CTLs, have been shown to have the ability to kill cancer cells. Our T-cell product candidates arise from a platform technology designed to produce off-the-shelf, partially human leukocyte antigen, or HLA, matched cellular therapeutics utilizing CTLs. We licensed rights to these product candidates from Memorial Sloan Kettering Cancer Center, or MSK, in June 2015. ... More ...
Where does ATRA fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-2.24|
|Quarterly EPS Est:||-0.68|